衍生集團(06893.HK)雲浮市產業園將於下月投產
衍生集團(06893.HK)公布,位於雲浮市健康醫藥產業園的建設(連同相關檢查)已於今年4月30日完成,而於5月8日,衍生健康醫藥已獲得中國有關當局頒發的食品生產許可SC認證,即是表明生產廠房的所有相關方面均符合相關檢查標準並獲得批准。該生產廠房預計將於今年6月開始生產集團自有品牌的保健食品。
展望未來,隨著生產廠房的運營,預計集團將能夠提供研發、加工、產品檢驗、品牌管理以及銷售和促銷服務。同時預計該生產廠房將能夠為主要為食品和飲料行業的OEM和ODM提供服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.